trusted by 100+ Patients

RGCC Onconomics Panels

Gain Accurate Cancer Insights with RGCC Onconomics Panels

Treatment Intro

Personalized insights for targeted cancer therapy.

Vervé Wellness uses advanced molecular diagnostics as a basis for preventative health. The RGCC Onconomics Panels provide comprehensive genomic profiling that helps identify the most effective therapies, drug sensitivities, and resistance patterns, allowing practitioners to tailor treatment based on each person’s unique cellular response.

About the Treatment

What are RGCC Onconomics Panels?

The RGCC Onconomics Panels are advanced diagnostic tests designed to evaluate how an individual’s cancer cells respond to a broad range of anticancer drugs and natural substances. Using live circulating tumor cells (CTCs) isolated from a blood sample, the test assesses both genetic and phenotypic behavior, providing crucial data to design a truly personalized oncology treatment plan.

Through molecular analysis, these panels help identify which chemotherapy or targeted drugs are most effective. It also analyzes which natural agents or complementary compounds can support treatment and assesses resistance mechanisms that could limit drug efficacy.

These comprehensive insights help clinicians make informed, individualized decisions that can enhance treatment outcomes, minimize unnecessary side effects, and improve a person’s quality of life.

How it Works

The Science Behind RGCC Onconomics Panels: How It Works

The RGCC Onconomics Panels use a proprietary process combining cell culture, molecular profiling, and drug sensitivity testing to evaluate how tumor cells behave.
Once circulating tumor cells are isolated from a blood sample, RGCC (Research Genetic Cancer Centre) will analyze cellular response across multiple drug categories:
Chemotherapy Agents
Check Mark
Targeted Therapies
Check Mark
Natural Compounds
Check Mark
Resistance Mechanisms
Check Mark
Cellular Pathways
Check Mark
With this accurate data, clinicians can choose treatments that align with each person’s unique cancer biology.

Key Benefits

Key Benefits of RGCC Onconomics Panels

🧬

Personalized Cancer Therapy

Delivers detailed analysis to match treatments with the client’s unique tumor profile.
🧫

Predicts Drug Response & Resistance

Identifies which drugs your cancer cells are most or least sensitive to.
🌸

Integrative Oncology Support

Includes testing for natural compounds that complement standard therapies.
🔬

Comprehensive Molecular Insights

Analyzes cellular genetics and behavior for a deeper understanding of tumor biology.
🧪

Non-Invasive & Highly Accurate

Uses a blood sample to isolate circulating tumor cells (CTCs).
♻️

Guides Long-Term Treatment Planning

Helps monitor treatment effectiveness and adjust therapies as cancer evolves.

Advanced diagnostics. Regenerative therapies. Personalised wellness plans.

Advanced diagnostics. Regenerative therapies. Personalised wellness plans.

Perfect for

Are RGCC Onconomics Panels Right for You?

This test is ideal for:
Clients seeking personalized cancer treatment based on their biology.
Individuals who have experienced limited response to conventional therapies.
Clinicians aiming to optimize drug selection and dosage for best outcomes.
People exploring integrative oncology approaches combining medical and natural treatments.
Those looking to minimize side effects and avoid unnecessary drug toxicity.
People with rare, aggressive, or treatment-resistant cancers.
Anyone seeking deeper insight into cancer progression and recurrence prevention.

The Process

What Do RGCC Onconomics Panels Look Like?

The RGCC Onconomics Panels follow a systematic process to deliver actionable results for personalized treatment.
Book a consultation
01
Consultation
A clinician reviews your medical history and cancer type to determine which Onconomics test is most suitable.
02
Blood Collection
A blood sample is drawn and sent to RGCC’s specialized laboratory for circulating tumor cell isolation and analysis.
03
Cellular & Molecular Analysis
Tumor cells are cultured, tested against various drugs and compounds, and analyzed for genetic mutations, pathways, and resistance mechanisms.
04
Detailed Report Delivery
Within approximately 2–3 weeks, a comprehensive report is provided outlining drug sensitivities, resistance profiles, and potential therapeutic recommendations.
05
Personalized Treatment Plan
Your healthcare provider uses these findings to create or refine a personalized treatment plan, combining medical, complementary, and lifestyle-based strategies for optimal outcomes.

FAQs

01

Is RGCC Onconomics Testing safe?

Yes. The test is non-invasive, requiring only a standard blood draw, with no additional risks beyond typical phlebotomy procedures.

02

How long does it take to get results?

Typically, results are available within 2–3 weeks after the sample reaches the RGCC laboratory.

03

Can this test replace a biopsy?

While not a direct replacement, RGCC testing offers a real-time, dynamic analysis of circulating tumor cells, complementing biopsy-based diagnostics and tracking cancer behavior over time.

04

Who performs the testing?

Testing is conducted at RGCC’s internationally accredited laboratories, following strict scientific and ethical standards for cellular analysis and data confidentiality.

05

Can RGCC Onconomics Panels be used for follow-up or relapse monitoring?

Yes. The test can be repeated over time to track changes in tumor behavior, monitor treatment response, and adjust therapy as cancer evolves or if recurrence occurs.

06

Do I need to stop treatment before taking the test?

Generally, patients don’t need to interrupt ongoing treatment. However, your physician may recommend timing the test strategically, such as before starting a new therapy, to ensure the most accurate baseline results.